Introduction
The kidney filters 180 liters of plasma daily, through the glomerular filtration barrier, a highly specialized glomerular structure consisting of a fenestrated endothelial cell layer, a glomerular basement membrane (GBM), and a layer of epithelial cells called podocytes, wich cover the external side of the glomerular capillary loop ( ). The podocyte is a terminally differentiated epithelial cell immersed in 1
In addition to playing a structural role in the slit diaphragm, nephrin is a signaling molecule involved in several intracellular pathways within podocytes ( ). The clustering of nephrin in lipid rafts as demonstrated by antibody crosslinking induces activation of the 11 Src-family kinase Fyn, which binds to and phosphorylates the cytoplasmic domain of nephrin. The phosphorylated nephrin interacts with podocin, CD2-AP and the p85 subunit of phosphoinositide-3 kinase (PI3K), thereby activating the Akt signaling pathway ( ). 12 -14 Nephrin phosphorylation promotes the sequential recruitment of Nck and activated Wiskott-Aldrich syndrome protein (WASP) to lipid rafts. The Nck subfamily of adaptor proteins has two members, Nck1 and Nck2, each containing three N-terminal SH3 domains and a single C-terminal SH2 domain ( ). The SH3 domain of Nck interacts with N-WASP, whereas the SH2 domain binds to the cytoplasmic 13 domain of nephrin ( ). N-WASP, a member of the WASP family proteins, is a potent inducer of Arp2/3-mediated actin polymerization ( 13 ) . The Nck adaptor protein activates N-WASP and promotes cytoskeletal rearrangement ( ). Within lipid rafts, Fyn interacts with and 15 13 phosphorylates N-WASP ( , ). The interaction of Fyn with CD2-AP and synaptopodin links nephrin-mediated proximal signaling to 13 16 the actin cytoskeleton ( ). The slit diaphragm thus acts as a signaling platform on which multiple signals converge ( ). 17 4 We carried out subtractive and differential screening of mRNA abundance in the T-cells of MCNS patients experiencing a relapse. We identified (c-maf inducing protein), a gene encoding an 86-kDa protein, as significantly expressed in these patients ( ). The c-mip 18 predicted structure of c-mip includes an N-terminal region containing a pleckstrin homology domain (PH), a central region containing docking sites for 14-3-3 protein, protein kinase C (PKC), and extracellular signal-regulated kinase (ERK), an SH3 domain similar to the p85 regulatory subunit of PI3K and a C-terminal region containing a leucine-rich repeat (LRR) domain.
We report here a high abundance of c-mip in the podocytes of patients with acquired idiopathic nephrotic syndrome, which covers three differents types of lesions of unknown origin, including MCNS, a subset of FSGS, and MN, in which the pococyte is the main target of injury. A feature common to these diseases is generalized edema resulting from massive proteinuria, hypoalbuminemia and sodium retention. These conditions may be complicated by infectious and thromboembolic events. MCNS and FSGS account for 70 and 20 , % % respectively, of the cases of idiopathic nephrotic syndrome in children, and of these two diseases accounts for 25 each of the cases in % adults ( ). The hallmark of MCNS is an absence of inflammatory injury and immune complex deposits in the glomeruli, whereas 19 -21 FSGS is characterized by the adhesion of the glomerular tuft to Bowman s capsule ( ). MCNS seems to be a single reasonably uniform ' 
22
entity combining immune and podocyte disorders, whereas FSGS appears to be a heterogeneous disease, of immune or non-immune origins ( ). Membranous nephropathy, which is rare in children, is characterized by the presence of prominent immune complex deposits 23 between the podocytes and the glomerular basement membrane ( ). The effacement of podocyte foot processes is a common lesion 24
suggestive of cytoskeletal alterations.
The production of c-mip was also induced in an experimental mouse model of nephrotic proteinuria induced by LPS. 
Results c-mip is detected in the kidneys of patients with MCNS and other glomerular diseases
The pathogenesis of MCNS involves the dysfunction of lymphocytes and podocytes through an unknown mechanism ( ). This 23 syndrome can be induced into remission (defined by the disappearance of proteinuria) following steroid therapy, but relapses are frequent and may require the initiation of cyclosporine treatment. Our initial studies of c-mip led us to examine whether the abundance of c-mip increased in the podocytes of patients with MCNS. We screened 15 adult patients with MCNS relapse ( ). In situ hybridization Table S1 (ISH) with an antisense probe revealed a signal that was largely restricted to the podocytes; this finding was confirmed by c-mip immunohistochemical analysis with a rabbit polyclonal antibody directed against c-mip ( ). We carried out confocal microscopy Fig 1A analyses of kidney biopsy specimens labeled with c-mip and nephrin antibodies. We were unable to detect c-mip in normal human kidney, either in the glomeruli or in extra-glomerular structures, whereas nephrin was clearly visualized ( , upper panel). By contrast, in Fig. 1B biopsy specimens from MCNS patients in relapse, c-mip was detectable and diffusely distributed along the external side of the capillary loops ( , lower panel). We analyzed the abundance of c-mip during remission, by carrying out immunolabeling for c-mip on kidney Fig. 1B biopsy specimens from five MCNS patients who were steroid sensitive but were nonetheless subject to frequent relapses and therefore received an additional cyclosporine-based therapy. c-mip was scarcely detected by immunohistochemical analysis in two patients and was undetectable in the other three patients ( ). Table S1 We screened patients with idiopathic MN, FSGS, HIV-associated nephropathy (HIVAN), IgA nephropathy and diabetic nephropathy.
All patients presented nephrotic proteinuria at the time of biopsy ( ). Kidney biopsy specimens from patients with primary FSGS Table S1 were analyzed by both ISH ( ) and immunohistochemistry ( ). We detected c-mip by these methods in only four of the 10 fig. S1 fig . S2 patients studied. In these cases, the course of the disease was complicated by frequent relapses requiring additional cyclosporine treatment.
The distribution of c-mip was similar to that observed in MCNS biopsies but less nephrin was detected. In the other patients with FSGS in whom c-mip was not detected, the glomerular disease occurred in the context of obesity and hypertension (4 patients), sarcoidosis (1 patient) and strongyloidiasis (1 patient). These results suggest that c-mip abundance may be increased in a particular subgroup of patients with FSGS, possibly those with disease of immune origin. The abundance of c-mip was found to be high in 11 of 12 biopsies of patients with idiopathic MN ( and ). We did not detect mRNA in the glomeruli of patients with nephrotic proteinuria caused by fig. S1 fig. S2 c-mip diabetic nephropathy, IgA nephropathy or HIVAN ( and ). These findings suggest that c-mip induction is not a Table S1 fig. S1
consequence of nephrotic proteinuria.
c-mip overproduction in podocytes inhibits nephrin phosphorylation and causes cytoskeletal disorganization in vitro
To understand the effects of c-mip on podocyte function, we established podocyte cell lines that stably expressed a tetracycline-inducible plasmid encoding c-mip. In non induced cells, c-mip was not detectable in podocytes, which displayed a well developed actin network with stress fibers (long intracellular bundles of actin filaments) (
). The induction of c-mip expression by Fig. 2A tetracycline was associated with a loss of stress fibers ( ). Fig. 2A Next, we sought to determine whether these morphological alterations were associated with changes in the abundance of proteins involved in podocyte signaling. We detected c-mip 48 hours after the addition of tetracycline ( ). The protein has a PH domain and Fig. 2B some proteins containing this domain are recruited to lipid rafts upon activation ( ). Fyn, which provides the early proximal signal, is 25 located in lipid rafts ( ). We therefore investigated the effects of c-mip on Fyn signaling. Immunoblotting of podocyte protein lysates 26
showed that c-mip overproduction triggered the accumulation of Fyn molecules phosphorylated at the Tyr residue (pTyr -Fyn), 528 528 suggesting that c-mip prevents Fyn activation ( ). Consequently, the amount of phosphorylated nephrin (p-nephrin) was reduced affect the protein abundance of CD2-AP and podocin ( ). Taken together, these results suggest that c-mip interferes with proximal Fig. 2B signals, inhibits nephrin activation and promotes actin cytoskeleton disorganization.
c-mip transgenic mice develop nephrotic proteinuria without inflammatory lesions or cell infiltration
To analyze the functional consequences of c-mip upregulation , we used a targeting system in which a single copy of the in vivo transgene was inserted into the ( ) locus X-linked hypoxanthine phosphoribosyltransferase 1 hypoxanthine phosphoribosyltransferase Hprt by homologous recombination ( ). A cDNA containing the coding sequence of was inserted under the control of the nephrin fig. S3 c-mip promoter to drive expression in podocytes. The founders were crossed with wild-type C57Bl/6 and back-crossed repeatedly to c-mip obtain a homogeneous C57BL/6 genetic background. All the mice analyzed here were hemizygous males Tg( ) from the F4 to F10 or complement deposits were observed on immunofluorescence analysis ( , lower panel). We did not detect c-mip either in tubular fig. S5 structures or in the interstitium. Pathological examinations of other organs did not reveal any common alterations and no abnormal mortality was noted during the observation period.
We assessed the amount of c-mip protein in MCNS and Tg( ) glomeruli, by incubating tissue sections with an anti-c-mip antibody, + followed by an FITC-conjugated secondary antibody, and examining three-dimensional images throughout the entire thickness of the glomeruli (20 images per glomerulus), by confocal microscopy. We quantified the fluorescence of the most representative slice from the image stack. Given the differences in size between the glomeruli of mice and humans, precluding direct comparison, we quantified the site-specific fluorescent labeling lining the capillary loop, and normalized the value obtained by dividing it by total glomerular area, for each glomerulus ( and ). Electron microscopy analysis of glomeruli in Tg( ) mice revealed the effacement of foot processes with flattened podocytes (as + usually observed in patients with nephrotic proteinuria), whereas wild-type mice had normal foot processes ( ). Slit were normal. Immunogold labeling revealed that c-mip was predominantly, but not exclusively located in the major and secondary foot processes close to the slit diaphragm ( ). fig. S4 4 15 We followed the course of glomerular disease in Tg( ) mice, from birth until the age of one year. Semi-quantitative determinations of + urinary protein levels were carried out with a dipstick in newborn mice of the F7 generation ( ). Proteinuria was detected in 70 of 
The podocytes of c-mip transgenic mice have an abnormal phenotype
We performed confocal microscopy analysis for various markers of mature podocytes. Nephrin and phosphorylated nephrin exhibited a continuous linear distribution along the peripheral capillary loop in wild-type mice. In Tg( ) glomeruli, the abundance of nephrin was + less abundant at the podocyte membrane, where granular staining was observed and lower amounts of nephrin phosphorylation were detected ( ). Our studies suggested that c-mip interfered with podocyte proximal activation ( ). Consistent with these fig. S9 in vitro Fig. 2B findings, eight-and ten-week-old Tg( ) mice had less phosphorylated nephrin than their wild-type littermates, although the total abundance + of nephrin was unchanged ( ). These alterations were associated with an increase in the abundance of the inactive forms of Fyn 
RNAi directed against c-mip prevents induction of proteinuria in LPS-treated mice
To determine whether the silencing of endogenous c-mip could prevent the development of proteinuria, we took advantage of our observations that the increase in c-mip abundance in LPS-treated mice occurred at the same time as the induction of proteinuria ( ). In this model, we confirmed that c-mip was present in podocyte foot processes and that it bound Fyn ( ). We detected c-mip mostly LPS-treated mice. However, we nevertheless investigated whether the induction of c-mip in podocytes from LPS-treated mice required T-cell activation. In SCID mice, which lack both cellular and humoral immunity, LPS injection induced significant proteinuria and an increase in c-mip abundance in podocytes ( ). observed for non-injected wild type mice (6.5 1.41 compared to 2.25 0.9, respectively), an effect that may be due to its cationic ± ± structure. Confocal immunofluorescence analysis showed that c-mip siRNA was efficiently delivered to podocytes ( ). The  Fig. 6C abundance of c-mip in podocytes was lower in mice injected with c-mip siRNA and LPS, and increased in mice receiving LPS alone (Fig.   ) . The amount of nephrin and phosphorylated nephrin appeared to be reduced in many glomeruli of LPS-treated mice, as compared 6C with mice treated with both siRNA and LPS ( ). The amount of phosphorylated Akt (pSer -Akt) was significantly reduced in LPS Fig. 7A 473 mice, whereas no significant difference was observed between siRNA-LPS and normal mice ( ). These results suggest that it may Fig. 7B be possible to prevent proximal signaling disorders and the development of proteinuria by inhibiting increases in the abundance of c-mip.
Discussion
The molecular pathogenesis of the most common acquired glomerular diseases associated with nephrotic syndrome remains to be elucidated. In this study, we provide evidence that: (i) the abundance of c-mip is selectively increased in the podocytes of patients with MCNS during relapse and decreased during remission; (ii) c-mip is detected in only a few patients with FSGS, confirming the heterogeneous nature of this entity, and in most patients with MN but not in other diseases with proteinuria in the nephrotic range analyzed to date; (iii) the overeproduction of c-mip in the podocytes of transgenic mice induces heavy proteinuria with podocyte foot process effacement, but without inflammatory lesions and immune complex deposits; (iv) c-mip binds Fyn and prevents the in vivo phosphorylation of nephrin and the recruitment of N-WASP and Nck, thus disturbing downstream signaling events, ultimately resulting in cytoskeleton disorganization and protein leakage; (v) the silencing of endogenous c-mip by RNAi prevents the induction of proteinuria in LPS-treated mice.
The higher abundance of c-mip in the podocytes of patients with MN, a glomerular disease characterized by subepithelial immune complex deposits, was unexpected. Like patients with MCNS, massive proteinuria in MN occurs in the absence of inflammatory cells (24 ) . In both experimental and human MN, immune complexes forming electron-dense deposits lead to complement activation and generation of the C5b-9/Mac complex, which in turn, induces alterations in the podocyte membrane and slit diaphragm, resulting in proteinuria ( ). 28
However, there are several lines of evidence to suggest that the mechanisms underlying the induction of proteinuria may be more complex.
First, the remission of nephrotic syndrome may be observed in patients with MN, despite the persistence of electron-dense deposits ( ), 29
which suggests that additional mechanisms may be required to alter slit diaphragm signaling. Second, active and passive Heymann nephritis can be induced in rats lacking complement component C6 and incapable of forming C5b-9 (also known as Mac) ( , ), 30 31 suggesting that the local activation of complement is not required for proteinuria induction. Third, the transplantation of kidneys from rats with Heymann nephritis, an experimental rat model of MN, into syngeneic hosts induces the clearing of subepithelial immune deposits with no decrease in proteinuria ( ). Fourth, both MCNS and MN podocytopathies are associated with a decrease in nephrin abundance 32
and changes in the distribution of nephrin ( ), as observed in our c-mip transgenic mice. The injuries initiating the nephrotic syndrome 33 differ in these two diseases targeting podocytes, but our results suggest that the underlying mechanisms may have signaling pathways in common and should be reconsidered in the light of our findings concerning c-mip induction.
T lymphocytes and podocytes constitutively produce several proteins such as CD2-AP, Fyn, and Nck, that play a key role in signaling and cytoskeleton reorganization in both these cell types. Mutations or experimental ablations of the genes encoding CD2-AP and Fyn are associated with glomerular filtration defects and immune disorders, respectively ( , ). By contrast, c-mip is, to our knowledge, the 34 35 first gene, shown to be quiescent under basal conditions but induced in both cell types in pathological situations, thus forming a bridge between immune alterations and podocyte dysfunction. Finally, the fact that transgenic mice expressing c-mip develop nephrotic syndrome, whereas silencing of endogenous c-mip prevents its development in LPS-treated mice suggests that c-mip plays an essential role in this disorder and identifies this protein as a potential key target for the development of new treatments.
Materials and Methods

Patients
The cohort of adult patients analyzed in this study was from our clinical department. The characteristics of these patients are summarized in . All adult patients with MCNS relapse had proteinuria levels exceeding 3 g per 24 h and severe Table S1 hypoalbuminemia at the time of blood sampling, which was performed before steroid treatment. The diagnosis of kidney disease was confirmed by renal biopsy. MCNS and MN were clinically classified as idiopathic in all cases.
The control cohort included adult patients with glomerular diseases with proteinuria in the nephrotic range. Normal renal samples were supplied by the hospital tissue bank (biological resource platform, H pital Henri Mondor). They were obtained from patients undergoing ô nephrectomy for a polar kidney tumor.
Immunohistochemistry and confocal microscopy hybridization (ISH) was performed as described elsewhere ( ). For immunofluorescence analyses, podocytes were cultured In situ 40
on Lab-Tek slides (Nalge Nunc, Rochester, New York) at a subconfluent density, then fixed by incubation with 2 paraformaldehyde and % 4 sucrose in phosphate-buffered saline (PBS) for 10 min at room temperature. Cells were permeabilized by incubation with 0.3 Triton % % X-100 for 10 min, and blocked by incubation in 1 bovine serum albumin (BSA) for 30 min. The slides were incubated overnight at 4 C %°w ith the indicated antibodies. They were then washed and incubated with the appropriate secondary biotinylated antibody (Vector Laboratories) for 10 min at room temperature, followed by a fluorescein-avidin DCS (Vector Laboratories). F-actin was visualized by incubation with FITC-conjugated phalloidin (Molecular Probes, Eugene, OR, USA). The slides were covered with Vectashield mounting medium containing DAPI, and viewed with a fluorescence microscope (Zeiss, Germany) using blue and green filters.
Immunohistochemistry studies on kidney sections were performed as described elsewhere ( ). Immunofluorescence studies on 40 kidney tissues were performed on 4 m cryostat sections fixed in acetone for 10 min, air-dried for 30 min at room temperature, then ) mice, totalling fifty glomeruli each, were analyzed. Tissue sections were viewed under a confocal laser scanning microscope + LSM510-META (Carl Zeiss, Germany) with a Plan-Apochromat 63x, 1.4 numerical aperture oil immersion objective. Acquisitions were performed with an argon laser (excitation wavelength 488 nm) and fluorescence emission was collected with the META channel between 500 and 600 nm. The pinhole was set at 1.0 Airy unit (0.8 mm optical slice thickness). The images were processed with ImageJ software ( , version 1.39e). The lower and upper thresholds of fluorescence intensity (F) were fixed at 2000 and 4095 pixels, http://rsb.info.nih.gov/ij/ respectively. We used a high cutoff value for the lower threshold to eliminate non specific signals. The area of specific labeling (lining the capillary loops) was normalized with respect to total glomerular area (S labeled area/total area) to account for the differences in total = glomerular areas between mice and humans. This ratio was determined for each glomerulus. The semiquantification (Q) of site-specific fluorescent labeling was determined as follows: Q F S. determined by densitometric analysis of Coomassie Blue-stained gels containing known amounts of BSA as standard.
Immunoprecipitations and Western blot analyses
The primary antibodies used in this study included anti-phospho-Akt (Ser and Thr ), anti-Akt, anti-N-WASP (Cell Signaling), Cell protein extracts from podocyte or HEK 293 cells were prepared in lysis buffer B (150 mM NaCl, 10 mM Tris HCl pH 7.5, 2 mM DTT, 10 glycerol, 1 mM EDTA, 1 NP40, 1 mM protease inhibitors, 1 mM NaF, and 1 mM sodium orthovanadate). BSA for 4 hours before use. The precleared protein lysates were incubated with the appropriate antibody for 2 hours at 4 C, and 50 l of°μ protein G-Sepharose beads were then added and the incubation was continued overnight at 4 C. The beads were washed six times with the° 8 15 lysis buffer B supplemented with 0.5 NP-40 and bound proteins were resolved by SDS-PAGE, in a 10 polyacrylamide gel, transferred % % to nitrocellulose membranes and processed for immunoblotting. The controls for the immunoprecipitations included the use of non immune rabbit IgG (Alpha Diagnostics Intl. Inc., San Antonio, USA) instead of primary antibody.
Generation of stable podocyte cell lines with inducible expression c-mip
Conditionally immortalized mouse podocytes have been described elsewhere ( ). Inducible podocyte cell lines were generated with 41 the T-Rex system (Invitrogen, Life Technologies). Before transfection, podocytes were maintained at 60 confluence, under permissive % conditions: RPMI 1640 medium containing 10 FCS, 100 U/ml penicillin, 100 g/ml streptomycin, 50 U/ml -INF, at 33 C. Podocytes
ere cotransfected with a expression plasmid (pcDNA4/TO) and a regulatory plasmid (pcDNA6/TR) encoding the Tet repressor. In c-mip the absence of tetracycline, the Tet repressor binds to the promoter of the inducible expression plasmid, preventing transcription. c-mip Cotransfection was performed with 1 g c-mip-pcDNA4/TO and 6 g pcDNA6/TR, with the Amaxa system (Amaxa GmbH, K hn,
Germany). A plasmid encoding the LacZ gene was used as a control. After transfection, the cells were allowed to recover for 24 hours in fresh RPMI medium, under permissive conditions. Dual selection was then performed by adding blasticidin (5 g/ml) and zeocin (125 μ μ g/ml). Podocytes were cultured under these conditions for four weeks, for the isolation of stable cell lines expressing both the Tet repressor and . Differentiation was induced by maintaining stable podocyte cell lines at 37 C without -interferon for 14 days in the presence c-mip °γ of blasticidin and zeocin. The expression of c-mip was induced on day 14, by adding tetracycline to the medium culture (1 g/ml) and μ incubating for 48 hours. Podocytes were then lysed for protein extraction. were injected into wild-type blastocytes, enhancing the contribution of the embryonic stem lineage to chimera and ensuring 100 germ % line transmission. Male chimeras with 100 brown coat color were crossed with wild-type (Wt) C57BL/6 females to obtain agouti % offspring. Female agouti offspring were backcrossed with Wt C57BL/6 males to obtain hemizygous male mice. Successive backcrosses were performed in order to obtain a homogeneous C57BL/6 genetic background (more than five generations). Mice were genotyped by PCR analysis of tail genomic DNA. We used one pair of primers specific for the transgene (the 5 primer was located in the nephrin ′ promoter, whereas the 3 primer was specific for c-mip) and another pair of murine primers that detects the wild-type HPRT allele in ′ heterozygous females, but not the reconstituted HPRT allele (containing part of the human HPRT gene) in homozygous females. The sizes of the and PCR products were 817 and 300 bp, respectively. c-mip HPRT All experiments involving animals were conducted in accordance with French laws.
Generation of c-mip transgenic mice
Proteinuria, serum albumin and creatinine analysis
Individual mice were housed in metabolic cages (Techniplast, France). Urine was collected over a 24-hour period and this process was repeated five times for each individual. Proteinuria (mg/ml) and serum albumin and creatinine concentrations (mg/ml) were measured with the appropriate kits from Advia Chemistry 1650 (Bayer Healthcare AG, Leverkusen, Germany). The urine of neonates was analyzed with urine dipsticks (Multistix; Bayer, Pittsburgh, Pa.). Urine samples (5 l) were analyzed by SDS-PAGE and the gels were stained with μ Coomassie Brilliant Blue.
Light and electron microscopy studies
For light microscopy, kidney from wild-type and c-mip-transgenic mice were incubated for 16 hours in Dubosq-Brazil, dehydrated, embedded in paraffin, cut into sections and stained with hematoxylin and eosin (H&E) or periodic acid-Schiff (PAS) reagent. We analyzed 9 15 The kidney specimens used for electron microscopy were cut into small pieces, fixed by incubation with 2.5 glutaraldehyde in 0.1 M % cacodylate buffer for one hour at pH 7.4, washed in the same buffer, post-fixed by incubation in 1 OsO for 45 min and placed in 0.5 Mann-Whitney tests were used for statistical analysis.
activity and stability assays of Stealth RNAi (siRNA) In vitro
We selected three sequences from the open reading frame and that are conserved between humans, rats and mice for testing in vitro.
The siRNA sequences were G6 (forward strand: UCCUGCUAUGAAGAGUUCAUCAACA), G8 (forward strand: CGGACCUUUCUCAGCAAGAUCCUCA), and G10 (forward strand: AAGAGUUCAUCAACAGCCGCGACAA). was inhibited by 60 by the siRNA G6 and by 85 for G8 and G10 . We selected siRNA G8 for experiments. The c-mip
in vivo stability of siRNA and its delivery to podocytes were confirmed with an siRNA targeting cyclophilin B coupled to Alexa Fluor 647 (a gift from Dr Xavier De Mollerat, Invitrogen, CA).
siRNA treatment
Six to eight-week-old male BALB/c mice weighing 20 22 g were purchased from the Charles River Laboratory (France). Labeled To determine whether podocyte induction of c-mip by LPS required T-cell or B-cell activation, SCID mice, which are deficient in T and B cells, were injected with LPS under similar conditions. We then analyzed the presence of c-mip by immunohistochemistry.
Statistics
The data presented are means SEM and were prepared with GraphPad Prism software, version 4.0. Mann-Whitney and ± Kruskal-Wallis tests were used to evaluate the significance of differences. Values of P < 0.05 were considered significant.
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